Sleep Quality in Patients With Rheumatoid Arthritis

An Investigation of Factors Affecting Sleep Quality in Patients With Rheumatoid Arthritis

This study was designed to investigate the factors affecting sleep quality of Rheumatoid arthritis patients in Turkish population.

Study Overview

Status

Completed

Detailed Description

Demographic data, duration of disease, routine biochemical tests and currently used medications were recorded. Disease activity was assessed with Disease Activity Score 28 (DAS 28). Visual Analog Scale (VAS) was used to evaluate pain levels. Health Assessment Questionnaire (HAQ) was used to assess activities of daily living. Beck depression inventory (BDI) was used to investigate the signs of depression in patients. Sleep quality was considered to be poor in patients with a Pittsburgh Sleep Quality Index (PSQI) global score of 5 and greater.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34186
        • Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Rheumatoid arthritis patients

Description

Inclusion Criteria:

  • patients with RA who met the 2010 American College of Rheumatology (ACR) RA classification criteria were included

Exclusion Criteria:

  • Patients who had difficulties understanding and responding to questions were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Case group
Rheumatoid arthritis patients who met the American College of Rheumatology (ACR) 2010 RA classification
no attempt was made to patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The factor affecting sleep quality of Rheumatoid arthritis patients
Time Frame: 1 day
Demographic data
1 day
duration of disease
Time Frame: 1 day
factor affecting sleep quality of Rheumatoid arthritis patients
1 day
Sleep quality of Rheumatoid arthritis patients
Time Frame: 1 day
Pittsburg Sleep Quality Index (PSQI) was used to evaluate the sleep quality of the patients. PSQI is a questionnaire which assesses sleep quality by questioning the patient on 7 main sections; i.e., subjective sleep quality, sleep latency, sleep duration, habitual sleep activity, sleep disorders, use of sleep medication and daytime dysfunctions. Questions are scored from 0 to 3, high scores reflecting poor sleep quality. Seven main components are first evaluated individually and then the scores are added. A total score of 5 and above indicates poor sleep quality
1 day
Disease activity of Rheumatoid arthritis patients
Time Frame: 1 day
Disease activity was assessed with Disease Activity Score 28 (DAS 28).
1 day
The pain evaluating of Rheumatoid arthritis patients
Time Frame: 1 day
Visual Analog Scale (VAS) was used to evaluate pain levels.
1 day
General health of Rheumatoid arthritis patients
Time Frame: 1 day
Health Assessment Questionnaire (HAQ) was used to assess activities of daily living.
1 day
Depression of Rheumatoid arthritis patients
Time Frame: 1 day
Beck depression inventory (BDI) was used to investigate the signs of depression in patients.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aysenur Bardak, MD, Istanbul Physical Therapy and Rehabilitation Research and Training Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2014

Primary Completion (Actual)

June 15, 2015

Study Completion (Actual)

October 15, 2018

Study Registration Dates

First Submitted

February 18, 2020

First Submitted That Met QC Criteria

February 19, 2020

First Posted (Actual)

February 20, 2020

Study Record Updates

Last Update Posted (Actual)

February 20, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on no attempt was made to patients

Subscribe